Modified new drug R&D is key for drug industry to survive.

Published: 2007-05-14 06:59:00

Updated: 2007-05-14 06:59:00

Director Yeo Jae-cheon of Korea Drug Research Association stressed to say under the title of "Today and tomorrow of our R&D for modified new drugs" in the Spring symposium of the Korea Society of Pharmaceutical Science on May 11 that the local drug industry should not look aside the importance of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK